SCHEMBL1683473

SCHEMBL1683473

COC(=O)c1cn2ncnc(Nc3cnc4[nH]ccc4c3F)c2c1C(C)C

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDR P35968 19/20 0.67
MAPK14 Q16539 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1683443 0.87 KDR (0.61) KDR
SCHEMBL1683477 0.83 KDR (0.61) KDRMAPK14
SCHEMBL1683431 0.80 KDR (1.00) KDR
SCHEMBL1683381 0.77 KDR (0.77) KDR
SCHEMBL1683413 0.76 KDR (1.00) KDR
SCHEMBL1683425 0.75 KDR (0.72) KDR
SCHEMBL1683420 0.75 KDR (0.72) KDR
SCHEMBL1683445 0.74 KDR (0.60) KDR
SCHEMBL1683447 0.74 KDR (0.60) KDR
SCHEMBL1683407 0.71 KDR (0.50) KDRMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539763-B1 AZAINDOLE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-04-13 EP claimed
EP-1539763-B1 AZAINDOLE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-04-13 EP disclosed